Imevax GmbH is located in München, Germany on Sendlinger Str. 60. Imevax GmbH is rated 3 out of 5 in the category biotechnology company in Germany. At ImevaX, we develop new vaccines against chronic and nosocomial infections. Our lead product is IMX101, a novel approach to fighting Helicobacter pylori.
Address
Sendlinger Str. 60